Form S-3ASR Mirum Pharmaceuticals,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/11/2026
- Wall Street ends down as expectations of Hormuz deal fade
- JPMorgan lifts S&P 500 target to 8,000 on strong earnings
- Nvidia and Wall Street giants plan $500B AI funding deal, FT reports
- Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
- Oil climbs 5% as Iran, US both demand compensation and Hormuz hopes fade
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
Mirum Pharmaceuticals (MIRM) Defended by Second Outlet, This time from Evercore: 'we think the move down is noise in a volatile tape this morning.'
February 26, 2026 10:50 AM ESTEvercore ISI analyst Gavin Clark-Gartner reiterated an Outperform rating and $101.00 price target on Mirum Pharmaceuticals (NASDAQ: MIRM).
The analyst comments "Am writing this on a plane so apologies if theres a lag. Getting at ton of questions on why stock is down ~15%. We dont... More
